²ý¼ªÖÎÔçйµÄ¼Û¸ñ(²ý¼ª»³ÔÐÈçºÎ¼ì²é³öÀ´) (½ñÈÕ¸üÐÂÖÐ)

(KGTV) ¡ª U.S. citizens traveling to Europe will have to be mindful of new visa rules after 2021.Starting on Jan. 21, 2021, Americans will need a ETIAS (European Travel Information and Authorization System) visa when traveling to a European Schengen-zone country, which includes Germany, France, Spain, Sweden, and Italy. Though, travelers heading to Ireland or the United Kingdom will not need the new visa.The visa will cost a one-time fee of about €7, or about to , according to a release from the European Union. The move is meant to improve security, "to avoid any further problems with illegal migration and terrorism," the ETIAS visa website says.Currently, U.S. citizens traveling to Europe for 90 days or less do not need a visa. Eventually, the new visa will be required for short-stay travel as well.To apply for a visa, Americans will need a valid passport, an email account, and a credit or debit card. Passports must be valid for three months beyond the period of an individual's intended stay.Americans will be required to have a ETIAS visa valid for three years when entering European Schengen-zone countries. The visa is a multiple-entry visa, allowing access to multiple countries. Minors must also apply for the visa.For more information on how to apply for the ETIAS visa, visit their website here. 1331

(SCRIPPS) -- The E.W. Scripps Company (NASDAQ: SSP) has named Leon Clark to the position of vice president and general manager of KGTV in San Diego, effective Nov. 19.Clark is currently vice president and general manager for KGUN and KWBA, Scripps¡¯ television stations in Tucson, Arizona. A southern California native, the new position will mark Clark¡¯s return to San Diego, where he worked for CBS in the late 2000s.¡°Leon has proven himself a seasoned leader across all areas of the Scripps Local Media business, and his understanding of the evolving news landscape will benefit the team in San Diego,¡± said Brian Lawlor, president of Local Media. ¡°I look forward to seeing the great work ahead for KGTV under Leon¡¯s leadership.¡±Clark joined Scripps in 2014, first leading Scripps¡¯ radio operations in Tucson. He then led the TV stations and, for a short time, led the radio and TV operations as general manager.Prior to his arrival at Scripps, Leon launched the sales operations on the West Coast for audio streaming company TuneIn and, before that, was market sales manager for CBS in Atlanta. In each of his management roles, at companies like Emmis Communications, Air America and Radio One, he has excelled in advertising sales, digital media, strategic partnerships and team building.¡°Heading back home to San Diego is an exciting opportunity as I look to the next chapter in my career,¡± said Clark. ¡°I have had an incredible experience with my colleagues in Tucson, and look forward to continuing my career with Scripps and helping San Diego continue its great work in that market.¡± *About Scripps * The E.W. Scripps Company (NASDAQ: SSP) serves audiences and businesses through a growing portfolio of local and national media brands. With 33 television stations, Scripps is one of the nation¡¯s largest independent TV station owners. Scripps runs a collection of national journalism and content businesses, including Newsy, the next-generation national news network; podcast industry leader Stitcher and its advertising network Midroll Media; and fast-growing national broadcast networks Bounce, Grit, Escape and Laff. Scripps produces original programming including ¡°Pickler & Ben,¡± runs an award-winning investigative reporting newsroom in Washington, D.C., and is the longtime steward of the Scripps National Spelling Bee. Founded in 1878, Scripps has held for decades to the motto, ¡°Give light and the people will find their own way.¡±*Investor contact: * Carolyn Micheli, The E.W. Scripps Company, 513-977-3732, Carolyn.micheli@scripps.com*Media contact: * Kari Wethington, The E.W. Scripps Company, 513-977-3763, Kari.wethington@scripps.com 2670

.....Financial Statements, from the time I announced I was going to run for President, showing all properties, assets and debts. It is a very IMPRESSIVE Statement, and also shows that I am the only President on record to give up my yearly 0,000 plus Presidential Salary!¡ª Donald J. Trump (@realDonaldTrump) September 28, 2020 338

(KGTV) - While support for medical marijuana is speeding up on a state level and in nationwide opinion polls, federal advancement is slowing due to research and approval gridlock. There¡¯s no denying the popularity of marijuana in the United States, with THC and cannabis products approved for medical use in 33 states. Recreational use is supported in 11 states, including California. The election results are echoed in a 2016 Quinnipiac University poll which showed 81 percent of Americans support medical marijuana legalization. California's support of medical marijuana started more than two decades ago when voters passed Proposition 215, the ¡°Compassionate Use Act of 1996.¡± Laws calling for regulation of medical marijuana were passed in 2015 and 2016, with recreational marijuana becoming legal in 2018. While voters increasingly approve marijuana legalization in various states across the country, the federal government has been slower to grant permission for use. RELATED: Timeline: How marijuana laws have changed in California In 1970, the Drug Enforcement Agency rated marijuana as a Schedule I controlled substance, defined as having a high potential for abuse with no accepted medical use for treatment. Almost 50 years later, the Federal Drug Administration has not approved marketing cannabis for the treatment of any condition. However, four cannabis derived or related products have been approved for use with a prescription from a licensed healthcare provider. Epidiolex contains a purified form of CBD for treating seizures associated with Lennox-Gastaut or Dravet syndrome in patients as young as 2 years old, according to the FDA. Also approved by the agency are Marinol and Syndros, used for treating weight loss in AIDS patients. RELATED: Judge: California child can take cannabis drug to school In order to approve drugs, the FDA relies on applicants and scientific investigators to conduct research. ¡°The FDA is aware that several states have either passed laws that remove state restrictions on the medical use of cannabis and its derivatives or are considering doing so. It is important to conduct medical research into the safety and effectiveness of cannabis products through adequate and well-controlled clinical trials,¡± FDA officials report. The agency said it supports medical marijuana research by providing information about the process to conduct the research and requirements needed to develop a cannabis-derived drug, supporting developers through meetings and regular interactions, and providing general support. RELATED: UC San Diego to study cannabis impact on essential tremor Research is expanding to meet public demand for new medical treatments. In 2017, the National Institutes of Health supported 330 projects focusing on therapeutic properties of cannabinoids and CBD. 2826

(KGTV) - Tired of turkey after Thanksgiving? DoorDash has a deal for Black FRYday.The app-based delivery service is giving away 15,000 orders of french fries for free on Friday, Nov. 23.Customers must place a door dash order of or more from the following restaurants: 278

À´Ô´£º×ÊÑô±¨